Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Caraway is providing college women+ with integrated mental, reproductive, and physical healthcare.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Clerkie is an AI financial planner that provides financial knowledge, personalized answers, and actionable plans.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
Dataiku operates as an enterprise artificial intelligence and machine-learning platform.
Nu Ride is a company expanding into insurance distribution and wealth advisory services through acquisitions.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Flvrs is a shoppable video platform that combines premium food content and commerce for foodies.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs.
Cityblock Health is a tech-driven healthcare provider that offers comprehensive and personalised care for underserved communities.
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
Powering the $648b care economy.
Guild is a learning platform that offers classes, programs, and degrees for working adults.
SpotOn provides mobile payment technology and a management system for restaurants and small businesses.
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
nCino provides a cloud banking platform that helps financial institutions modernize their operations and improve the customer experience.
Wellington Management has invested in 282 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Wellington Management's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 56 different industry categories.
Among tracked funding rounds, Blueprint Medicines received $1.3B in a Post-IPO Equity round. Wellington Management's total known invested capital is $78.3B.
Wellington Management's average investment size is $277.6M across its portfolio of 282 companies.
Recent Wellington Management portfolio additions include Black Diamond Therapeutics, Caraway, Upstream Bio, Alkeus Pharmaceuticals, Boundless Bio. These companies were founded in 2020 or later.